Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2018/4327904 http://scihub22266oqcxt.onion/10.1155/2018/4327904 C6051109!6051109!30057830     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Case+Rep+Hematol 2018 ; 2018 (ä): ä Nephropedia Template TP {{tp|p=30057830|t=2018. Thrombotic Thrombocytopenic Purpura Associated with Pazopanib |pdf=|usr=}}{{30057830}} gab.com Text Thrombotic Thrombocytopenic Purpura Associated with Pazopanib JO: Case Rep Hematol http://www.kidney.de/pget.php?&tw=1&pmid=30057830 #FOAvip A 76-year-old male with metastatic renal carcinoma on day 24 of pazopanib was admitted with complaints of emesis, confusion, and hematuria. Laboratory testing showed acute kidney injury, hyperbilirubinemia, and thrombocytopenia. Scattered schistocytes were seen on peripheral smear, and he was diagnosed with thrombotic microangiopathy (TMA). He was started on daily, one-volume plasma exchange with rapid improvement in thrombocytopenia. ADAMTS13 activity returned as undetectably low with no inhibitor detected. After cessation of plasmapheresis, repeat ADAMTS13 activity returned as normal. Unfortunately, his platelet count started to downtrend within four days after developing septicemia thought to be due to a catheter-associated infection. He was placed on comfort care measures after discussion with his family. An autopsy listed the major cause of death as metastatic renal cell carcinoma. According to two separate systematic reviews, there have been no cases of proven drug-induced TMA where decreased ADAMTS13 activity was the identified mechanism. While pazopanib is also associated with TMA, this unique case suggests a novel potential mechanism for TMA associated with pazopanib and brings forth ?drug-induced thrombotic thrombocytopenic purpura? that quickly responds to plasmapheresis as a possible new diagnostic entity requiring prompt recognition and treatment. Twit Text FOAVip Thrombotic Thrombocytopenic Purpura Associated with Pazopanib ????Case Rep Hematol http://www.kidney.de/pget.php?&tw=1&pmid=30057830 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30057830 #FOAvip English Wikipedia <ref>{{Cite pmid|30057830}}</ref> Thrombotic Thrombocytopenic Purpura Associated with Pazopanib #MMPMID30057830 Syed U; Wahlberg KJ; Douce DR; Sprague JR Case Rep Hematol 2018[]; 2018 (ä): ä PMID30057830show ga A 76-year-old male with metastatic renal carcinoma on day 24 of pazopanib was admitted with complaints of emesis, confusion, and hematuria. Laboratory testing showed acute kidney injury, hyperbilirubinemia, and thrombocytopenia. Scattered schistocytes were seen on peripheral smear, and he was diagnosed with thrombotic microangiopathy (TMA). He was started on daily, one-volume plasma exchange with rapid improvement in thrombocytopenia. ADAMTS13 activity returned as undetectably low with no inhibitor detected. After cessation of plasmapheresis, repeat ADAMTS13 activity returned as normal. Unfortunately, his platelet count started to downtrend within four days after developing septicemia thought to be due to a catheter-associated infection. He was placed on comfort care measures after discussion with his family. An autopsy listed the major cause of death as metastatic renal cell carcinoma. According to two separate systematic reviews, there have been no cases of proven drug-induced TMA where decreased ADAMTS13 activity was the identified mechanism. While pazopanib is also associated with TMA, this unique case suggests a novel potential mechanism for TMA associated with pazopanib and brings forth ?drug-induced thrombotic thrombocytopenic purpura? that quickly responds to plasmapheresis as a possible new diagnostic entity requiring prompt recognition and treatment. äThrombotic Thrombocytopenic Purpura Associated with Pazopanib (epmc).pdf DeepDyve Pubget Overpricing